Your browser doesn't support javascript.
loading
Diagnostic Utility of Glial Fibrillary Acidic Protein Beyond 12 Hours After Traumatic Brain Injury: A TRACK-TBI Study.
Puccio, Ava M; Yue, John K; Korley, Frederick K; Okonkwo, David O; Diaz-Arrastia, Ramon; Yuh, Esther L; Ferguson, Adam R; Mukherjee, Pratik; Wang, Kevin K W; Taylor, Sabrina R; Deng, Hansen; Markowitz, Amy J; Sun, Xiaoying; Jain, Sonia; Manley, Geoffrey T.
Afiliação
  • Puccio AM; Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Yue JK; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
  • Korley FK; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, USA.
  • Okonkwo DO; Department of Emergency Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Diaz-Arrastia R; Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Yuh EL; Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Ferguson AR; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, USA.
  • Mukherjee P; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA.
  • Wang KKW; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
  • Taylor SR; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, USA.
  • Deng H; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, USA.
  • Markowitz AJ; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, USA.
  • Sun X; Center for Neurotrauma, Multiomics and Biomarkers, Morehouse School of Medicine, Atlanta, Georgia, USA.
  • Jain S; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
  • Manley GT; Brain and Spinal Injury Center, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, USA.
J Neurotrauma ; 41(11-12): 1353-1363, 2024 06.
Article em En | MEDLINE | ID: mdl-38251868
ABSTRACT
Blood levels of glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase-L1 (UCH-L1) within 12h of suspected traumatic brain injury (TBI) have been approved by the Food and Drug administration to aid in determining the need for a brain computed tomography (CT) scan. The current study aimed to determine whether this context of use can be expanded beyond 12h post-TBI in patients presenting with Glasgow Coma Scale (GCS) 13-15. The prospective, 18-center Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study enrolled TBI participants aged ≥17 years who presented to a United States Level 1 trauma center and received a clinically indicated brain CT scan within 24h post-injury, a blood draw within 24h and at 14 days for biomarker analysis. Data from participants with emergency department arrival GCS 13-15 and biomarker values at days 1 and 14 were extracted for the primary analysis. A subgroup of hospitalized participants with serial biomarkers at days 1, 3, 5, and 14 were analyzed, including plasma GFAP and UCH-L1, and serum neuron-specific enolase (NSE) and S100 calcium-binding protein B (S100B). The primary analysis compared biomarker values dichotomized by head CT results (CT+/CT-). Area under receiver-operating characteristic curve (AUC) was used to determine diagnostic accuracy. The overall cohort included 1142 participants with initial GCS 13-15, with mean age 39.8 years, 65% male, and 73% Caucasian. The GFAP provided good discrimination in the overall cohort at days 1 (AUC = 0.82) and 14 (AUC = 0.72), and in the hospitalized subgroup at days 1 (AUC = 0.84), 3 (AUC = 0.88), 5 (AUC = 0.82), and 14 (AUC = 0.74). The UCH-L1, NSE, and S100B did not perform well (AUC = 0.51-0.57 across time points). This study demonstrates the utility of GFAP to aid in decision-making for diagnostic brain CT imaging beyond the 12h time frame in patients with TBI who have a GCS 13-15.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Ubiquitina Tiolesterase / Lesões Encefálicas Traumáticas / Proteína Glial Fibrilar Ácida Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Ubiquitina Tiolesterase / Lesões Encefálicas Traumáticas / Proteína Glial Fibrilar Ácida Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos